Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $47.9B |
| Sales growthchange from the year before | +1.9% |
| Gross marginshare of sales left after the direct cost of what it sells | 61.6% |
| Operating marginshare of sales left after running the business | 28.7% |
| Net marginshare of sales kept as profit | 27.3% |
| Free-cash-flow marginspare cash generated per $100 of sales | 11.0% |
| Return on invested capitalprofit made on each $100 put into the business | 33.8% |
| Return on equityprofit vs. shareholders' accounting value | 40.7% |
| Interest coverhow many times profit covers interest payments | 8.3x |
| Change in share countnegative = the company is buying back its shares | -0.2% |
3 insiders sold $67.6M (80% under pre-arranged plans) on the open market.
| Murphy JohnPresident and CFO | SoldJul 31 | 152,483 shat $87.31 · $13.3M |
| Quincey JamesChairman · Director | Sold (plan)Jul 29 | 145,947 shat $90.09 · $13.1M |
| Quincey JamesChairman · Director | Sold (plan)Jul 28 | 381,140 shat $90.04 · $34.3M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy